CTOs on the Move

RRD International, LLC

www.rrdintl.com

 
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.rrdintl.com
  • 7361 Calhoun Pl Ste 510
    Rockville, MD USA 20855
  • Phone: 301.762.6100

Executives

Name Title Contact Details

Similar Companies

Portamedic

Portamedic is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

T3D Therapeutics

T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.

The Exigent Group

The Exigent Group is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nsight Health

Nsight is a company that provides remote patient monitoring, chronic care management, and behavioral health integration services to healthcare providers. Their services include medical devices, EHR integrated software, and a 24/7 clinical team.

Flugen

FluGen is driving the development of a universal flu vaccine to advance human health.